Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NNVC

NanoViricides (NNVC)

NanoViricides Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NNVC
DateTimeSourceHeadlineSymbolCompany
03/19/201811:12AMPR Newswire (US)NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the Unive...AMEX:NNVCNanoViricides Inc
02/21/20187:00AMPR Newswire (US)NanoViricides Files Quarterly Report for Period Ending December 31, 2017AMEX:NNVCNanoViricides Inc
02/20/20181:55PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
02/14/20185:57PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)AMEX:NNVCNanoViricides Inc
12/15/201710:29AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
12/06/20177:00AMPR Newswire (US)Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles CandidatesAMEX:NNVCNanoViricides Inc
11/22/20174:23PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:NNVCNanoViricides Inc
11/20/20177:00AMPR Newswire (US)NanoViricides Files Quarterly Report for Period Ending September 30, 2017AMEX:NNVCNanoViricides Inc
11/14/20175:25PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
11/08/20175:18PMEdgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)AMEX:NNVCNanoViricides Inc
11/06/20177:00AMPR Newswire (US)NanoViricides Provides Further Details on Its Herpes-Induced Acute Retinal Necrosis Animal Study to be Presented On November ...AMEX:NNVCNanoViricides Inc
10/27/20176:08AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:NNVCNanoViricides Inc
10/26/20177:00AMPR Newswire (US)Excellent Results in Inhibiting Shingles Virus in Human Skin: NanoViricides Extends Agreement with SUNY Upstate Medical Cente...AMEX:NNVCNanoViricides Inc
10/17/20177:00AMPR Newswire (US)NanoViricides to Present Results On Successful Treatment Of Herpes-Induced Acute Retinal Necrosis at the Annual Meeting of th...AMEX:NNVCNanoViricides Inc
09/29/20177:30AMPR Newswire (US)NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical TrialsAMEX:NNVCNanoViricides Inc
09/28/20174:51PMEdgar (US Regulatory)Annual Report (10-k)AMEX:NNVCNanoViricides Inc
09/11/20179:04AMPR Newswire (US)NanoViricides, Inc. Announces its CEO Dr. Seymour to Present at the 19th Annual Rodman & Renshaw Global Investment Conference...AMEX:NNVCNanoViricides Inc
07/10/20177:00AMPR Newswire (US)NanoViricides Reports Its Drug Candidates Significantly Reduced the Extent of Shingles Virus Infection of Human SkinAMEX:NNVCNanoViricides Inc
06/26/20179:00AMPR Newswire (US)NanoViricides' Poster "Novel Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented...AMEX:NNVCNanoViricides Inc
06/20/20177:00AMPR Newswire (US)NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of VirologyAMEX:NNVCNanoViricides Inc
06/13/20177:00AMPR Newswire (US)NanoViricides CEO to Present Information on Its Topical Shingles Treatment At the 2017 Marcum Investor Conference in New York...AMEX:NNVCNanoViricides Inc
06/06/20175:30PMPR Newswire (US)NanoViricides Reports Excellent Inhibitory Effects of Its Topical Shingles Treatment Candidates Against VZV in Multiple Cell ...AMEX:NNVCNanoViricides Inc
05/16/20177:50AMPR Newswire (US)NanoViricides Files Quarterly Report for Period Ending 2017-03-31AMEX:NNVCNanoViricides Inc
05/15/20175:03PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
04/26/20175:00PMPR Newswire (US)NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Compan...AMEX:NNVCNanoViricides Inc
04/26/20176:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)AMEX:NNVCNanoViricides Inc
04/18/20174:57PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:NNVCNanoViricides Inc
03/01/20176:10AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:NNVCNanoViricides Inc
02/16/20177:00AMPR Newswire (US)NanoViricides Files Quarterly Report for Period Ending 2016-12-31AMEX:NNVCNanoViricides Inc
02/14/20176:02PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
 Showing the most relevant articles for your search:AMEX:NNVC